PublizoomAward notice Supplies
Spécialités pharmaceutiques à base de glecaprévir/pibrentasvir
Notice published in French. The AI analysis summarises it for you in your language.
- Public buyer
- Healthcare Public Procurement (HeCaPP)
Saint-Gilles\Sint-Gillis - Place of performance
- 1090 Bruxelles\Brussel, Brussels-Capital
- Amount awarded
- €2,856,000 excl. VAT
- Planned end of contract
- 13 August 2030
likely re-tender around February 2030 - Bids received
- 1
- Procedure
- oth-single
- Publication
- 18 August 2026
- Notice language
- French
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Spécialités pharmaceutiques à base de glecaprévir/pibrentasvir
Awarded to
- Abbvie SA BCE/KBO 0845.096.860
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €269,390
- Median
- €449,863
- A quarter above
- €962,736
Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 571617-2026.